These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29074831)

  • 41. [Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure].
    Ito M
    Clin Calcium; 2011 Nov; 21(11):119-25. PubMed ID: 22040828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Eldecalcitol (ED-71)].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Jan; 21(1):53-8. PubMed ID: 21187594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current Topics on Vitamin D. Protein interaction and biological action of active vitamin D compounds].
    Ono Y
    Clin Calcium; 2015 Mar; 25(3):387-94. PubMed ID: 25716812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Smith SY; Doyle N; Boyer M; Chouinard L; Saito H
    Bone; 2013 Nov; 57(1):116-22. PubMed ID: 23774444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism.
    Ritter CS; Brown AJ
    J Cell Biochem; 2011 May; 112(5):1348-52. PubMed ID: 21337382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium absorptive effects of vitamin D and its major metabolites.
    Heaney RP; Barger-Lux MJ; Dowell MS; Chen TC; Holick MF
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4111-6. PubMed ID: 9398723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent studies on the biological actions of vitamin D on intestinal transport and the electrophysiology of peripheral nerve and cardiac muscle.
    Wasserman RH; Brindak ME; Buddle MM; Cai Q; Davis FC; Fullmer CS; Gilmour RF; Hu C; Mykkanen HM; Tapper DN
    Prog Clin Biol Res; 1990; 332():99-126. PubMed ID: 2184443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antagonistic Actions in Vivo of (23S)-25-Dehydro-1alpha-Hydroxyvitamin D(3-)26,23-Lactone on Calcium Metabolism Induced by 1alpha,25-Dihydroxyvitamin D(3).
    Ishizuka S; Miura D; Ozono K; Chokki M; Mimura H; Norman AW
    Endocrinology; 2001 Jan; 142(1):59-67. PubMed ID: 11145567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
    Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium transport by rat colon in vitro.
    Harrison HC; Harrison HE
    Am J Physiol; 1969 Jul; 217(1):121-5. PubMed ID: 5785867
    [No Abstract]   [Full Text] [Related]  

  • 52. Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo.
    Harada S; Takeda S; Uno A; Takahashi F; Saito H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):281-3. PubMed ID: 20398764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update on recent progress in vitamin D research. Eldecalcitol
    Suzuki T
    Clin Calcium; 2017; 27(11):1595-1600. PubMed ID: 29074832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fall risk and fracture. Vitamin D and falls/fractures].
    Miyakoshi N
    Clin Calcium; 2013 May; 23(5):695-700. PubMed ID: 23628682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis.
    Lieben L; Carmeliet G
    Bone; 2013 Jun; 54(2):237-43. PubMed ID: 23072922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats.
    de Freitas PH; Hasegawa T; Takeda S; Sasaki M; Tabata C; Oda K; Li M; Saito H; Amizuka N
    Bone; 2011 Sep; 49(3):335-42. PubMed ID: 21664310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Update on recent progress in vitamin D research. Vitamin D and bone, mineral metabolism.].
    Masuyama R
    Clin Calcium; 2017; 27(11):1525-1532. PubMed ID: 29074824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vitamin D analogue, eldecalcitol, enhances expression of fast myosin heavy chain subtypes in differentiated C2C12 myoblasts.
    Saito H; Kishimoto KN; Mori Y; Okuno H; Tanaka M; Itoi E
    J Orthop Sci; 2017 Mar; 22(2):345-350. PubMed ID: 28017710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control.
    Lucas PA; Brown RC; Drüeke T; Lacour B; Metz JA; McCarron DA
    J Clin Invest; 1986 Jul; 78(1):221-7. PubMed ID: 3755141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.